seretide 125 evohaler pressurised inhalation suspension 25mcg/125mcg
glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - salmeterol, fluticasone propionate - pressurised inhalation, suspension - salmeterol 25 µg fluticasone propionate 125 µg - drugs for obstructive airway diseases
seretide 250 evohaler pressurised inhalation suspension 25mcg/250mcg
glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - salmeterol, fluticasone propionate - pressurised inhalation, suspension - salmeterol 25 µg fluticasone propionate 250 µg - drugs for obstructive airway diseases
sereflo 25 microgram/125 microgram per actuation pressurised inhalation, suspension
fannin limited - fluticasone propionate; salmeterol xinafoate - pressurised inhalation, suspension - 25 / 125 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone
sereflo 25 microgram/250 microgram per actuation pressurised inhalation, suspension
fannin limited - fluticasone propionate; salmeterol xinafoate - pressurised inhalation, suspension - 25/250 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone
asmol cfc-free inhaler salbutamol 100 microgram (as sulfate) pressurised inhaler metered dose
alphapharm pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.
ventolin inhaler cfc-free salbutamol 100 microgram (as sulfate) pressurised inhaler metered dose
glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. indications: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.
ventolin inhaler cfc-free salbutamol 100 microgram (as sulfate) pressurised inhaler metered dose (with counter)
glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. indications: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.
seretide 125 evohaler
pharmaram ltd - fluticasone propionate; salmeterol xinafoate - pressurised inhalation - 125microgram/1dose ; 25microgram/1dose
seretide 250 evohaler
pharmaram ltd - fluticasone propionate; salmeterol xinafoate - pressurised inhalation - 250microgram/1dose ; 25microgram/1dose
serevent inhaler cfc-free
glaxosmithkline south africa (pty) limited - inhaler - see ingredients - each metered dose delivers salmeterol 25,0 ug